InvestorsObserver
×
News Home

AbbVie (ABBV) to Present at the Bank of America Securities Healthcare Conference

Monday, May 06, 2024 09:17 AM | MarijuanaStocks.com via QuoteMedia

AbbVie (ABBV) to Present at the Bank of America Securities Healthcare Conference

2024-05-06 09:17:55 ET

AbbVie to Present at the Bank of America Securities Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024. Robert A. Michael, president and chief operating officer, Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., senior vice president, chief medical officer, global therapeutics, will present at 12:40 p.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

AbbVie logo
AbbVie logo

CisionCision
Cision
View original content to download multimedia: https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bank-of-america-securities-healthcare-conference-302133591.html

SOURCE AbbVie

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App